Univ Sao Paulo, Dept Otolaryngol, Sao Paulo, BrazilUniv Sao Paulo, Dept Allergy & Immunol, Sao Paulo, BrazilUniv Fed Bahia, Dept Pneumol, Salvador, BA, BrazilUniv Fed Parana, Dept Otolaryngol, BR-80060000 Curitiba, Parana, BrazilABC Med Sch, Dept Otolaryngol, Santo Andre, BrazilSao Paulo State Med Hosp, Allergy & Immunol Dept, Sao Paulo, BrazilGoiania Med Sch, Allergy & Immunol Dept, Goiania, Go, BrazilSorocaba Hosp, Allergy & Immunol Dept, Sorocaba, BrazilUniv Fed Sao Paulo, Allergy & Immunol Dept, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Otolaryngol, Sao Paulo, BrazilUniv Fed Minas Gerais, Dept Otolaryngol, Belo Horizonte, MG, BrazilUniv Fed Sao Paulo, Allergy & Immunol Dept, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Otolaryngol, Sao Pau...
Histamine is the primary mediator involved the pathophysiology of allergic rhinitis and chronic urti...
ABSTRACT INTRODUCTION: Allergic rhinitis is considered the most prevalent respiratory disease in Br...
In a review of rupatadine published in 2008, the primary focus was on its role as an antihistamine, ...
SummaryAllergic rhinitis affects 10-30% of the population, negatively impacting one's quality of lif...
FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent...
Allergic rhinitis affects 10-30% of the population, negatively impacting one's quality of life and p...
BACKGROUND: Allergic rhinitis has reached epidemic levels for years in Belgium and substantially imp...
International audienceBackground The clinical efficacy of rupatadine in terms of responders has not ...
Abstract: Allergic rhinitis is a common condition that affects 10%–20 % of general population. Seaso...
Abstract Background Different clinical trials showed the superior efficacy of rupatadine compared to...
Objective: Long-term safety and efficacy of 10- and 20-mg rupatadine in Japanese patients with peren...
The second-generation antihistamine rupatadine is a new long-acting and non-sedating drug that exert...
Background: Rupatadine is a novel non-sedating second-generation H1-antihistamine with antiplatelet-...
www.thepcrj.org doi:10.3132/pcrj.2008.00043 Pharmacological profile, efficacy and safety of rupatadi...
Background: Allergic rhinitis (AR) is one of the most prevalent atopic disorders that affect product...
Histamine is the primary mediator involved the pathophysiology of allergic rhinitis and chronic urti...
ABSTRACT INTRODUCTION: Allergic rhinitis is considered the most prevalent respiratory disease in Br...
In a review of rupatadine published in 2008, the primary focus was on its role as an antihistamine, ...
SummaryAllergic rhinitis affects 10-30% of the population, negatively impacting one's quality of lif...
FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent...
Allergic rhinitis affects 10-30% of the population, negatively impacting one's quality of life and p...
BACKGROUND: Allergic rhinitis has reached epidemic levels for years in Belgium and substantially imp...
International audienceBackground The clinical efficacy of rupatadine in terms of responders has not ...
Abstract: Allergic rhinitis is a common condition that affects 10%–20 % of general population. Seaso...
Abstract Background Different clinical trials showed the superior efficacy of rupatadine compared to...
Objective: Long-term safety and efficacy of 10- and 20-mg rupatadine in Japanese patients with peren...
The second-generation antihistamine rupatadine is a new long-acting and non-sedating drug that exert...
Background: Rupatadine is a novel non-sedating second-generation H1-antihistamine with antiplatelet-...
www.thepcrj.org doi:10.3132/pcrj.2008.00043 Pharmacological profile, efficacy and safety of rupatadi...
Background: Allergic rhinitis (AR) is one of the most prevalent atopic disorders that affect product...
Histamine is the primary mediator involved the pathophysiology of allergic rhinitis and chronic urti...
ABSTRACT INTRODUCTION: Allergic rhinitis is considered the most prevalent respiratory disease in Br...
In a review of rupatadine published in 2008, the primary focus was on its role as an antihistamine, ...